Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anlotinib”

481 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 481 results

Testing effectiveness (Phase 2)UnknownNCT04803851
What this trial is testing

Anlotinib Plus Anti-PD-1 Antibody AK105 for Advanced Pancreatic Cancer

Who this might be right for
AnlotinibAnti-PD-1 AntibodyAdvanced Pancreatic Cancer
Peking Union Medical College Hospital 29
Testing effectiveness (Phase 2)Study completedNCT04004572
What this trial is testing

Sintilimab, Pegaspargase and Anlotinib for Stage IV Natural Killer /T-cell Lymphoma

Who this might be right for
Natural Killer/T-Cell Lymphoma, Nasal and Nasal-Type
Rong Tao 37
Large-scale testing (Phase 3)Looking for participantsNCT07678229
What this trial is testing

BRIDGE-NK: Immunotherapy Versus Chemotherapy Induction Followed by Autologous HSCT in Advanced NKTCL

Who this might be right for
Extranodal NK/T-cell Lymphoma
Rong Tao 150
Testing effectiveness (Phase 2)Ended earlyNCT04924192
What this trial is testing

A Clinical Study of TQB3616 Capsules Combined With Anlotinib Hydrochloride Capsules or Standard Chemotherapy Second-line and Above in the Treatment of Advanced Lung Cancer

Who this might be right for
Advanced Lung Carcinoma
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 21
Testing effectiveness (Phase 2)UnknownNCT03672136
What this trial is testing

Concurrent Chemoradiotherapy Combination With Anlotinib for Unresectable Stage III NSCLC Patients

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Shandong Cancer Hospital and Institute 25
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07612098
What this trial is testing

Preoperative Radiotherapy and Anlotinib With or Without Penpulimab for Soft Tissue Sarcoma

Who this might be right for
Soft Tissue Sarcoma (STS)
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 274
Not applicableUnknownNCT05490667
What this trial is testing

Clinical Study of Anlotinib Combined With Chemotherapy in the Treatment of Unresectable Advanced Desmoid Tumor

Who this might be right for
Desmoid
Henan Cancer Hospital 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT04165330
What this trial is testing

Evaluation of AL3818 in Combination With Nivolumab in Solid Tumors

Who this might be right for
Solid Tumor, AdultSoft Tissue SarcomaNon Small Cell Lung Cancer+1 more
Sarcoma Oncology Research Center, LLC 56
Testing effectiveness (Phase 2)UnknownNCT04181372
What this trial is testing

Neoadjuvant Chemotherapy Plus Anlotinib in Stage III(N2) Non-small-cell Lung Cancer

Who this might be right for
Stage III Non-small-cell Lung Cancer
The First Affiliated Hospital of Guangzhou Medical University 50
Early research (Phase 1)Study completedNCT04967079
What this trial is testing

Trametinib Plus Anlotinib in Non-G12C KRAS-Mutant NSCLC Patients

Who this might be right for
Non Small Cell Lung Cancer
Shanghai Chest Hospital 33
Testing effectiveness (Phase 2)Looking for participantsNCT07601178
What this trial is testing

QUEEN-APPLE: A Single-Arm, Multicenter, Prospective Phase II Clinical Study of Iparomlimab and Tuvonralimab (QL1706) in Combination With Anlotinib Hydrochloride and Nab-Paclitaxel as First-Line Treatment for Advanced Triple-Negative Breast Cancer

Who this might be right for
TNBC, Triple Negative Breast Cancer
Jiangsu Cancer Institute & Hospital 34
Not applicableNot Yet RecruitingNCT06982287
What this trial is testing

A Retrospective Real-World Study on the Efficacy and Safety of Anlotinib Hydrochloride Combined With Immunotherapy Maintenance Therapy Following Standard Chemoimmunotherapy for ES-SCLC (ALTER-L059)

Who this might be right for
Small Cell Lung Cancer Extensive Stage
Yong Fang 100
Large-scale testing (Phase 3)UnknownNCT04809142
What this trial is testing

TQB2450 Injection Combined With Anlotinib Hydrochloride Capsule as Second-line Treatment in Subjects With Advanced Biliary Cancer

Who this might be right for
Advanced Biliary Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 392
Post-approval studies (Phase 4)Not Yet RecruitingNCT06356675
What this trial is testing

A Single-arm Pilot Study of Tislelizumab Combined With Anlotinib in Patients With Advanced NSCLC With Driver-negative After Progression to Immunotherapy

Who this might be right for
Advanced NSCLC
The First Affiliated Hospital, Guangzhou University of Traditional Chinese Medicine 33
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07239622
What this trial is testing

Liposomal Irinotecan Combined With Sintilimab and Anlotinib in the Treatment of Recurrent or Persistent Ovarian Clear Cell Carcinoma

Who this might be right for
Ovarian CancerOvarian Clear Cell Carcinoma
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 36
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06851169
What this trial is testing

This is a Two-cohort, Exploratory Clinical Study Assessing the Activity of Benmelstobart Alone or Combined with Anlotinib Administered Prior to Surgery in Terms of Pathological Complete Response

Who this might be right for
Non Small Cell Lung Cancer
Tang-Du Hospital 58
Large-scale testing (Phase 3)UnknownNCT03601975
What this trial is testing

Gemcitabine and Cisplatin With/Without Anlotinib in Advanced Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 336
Post-approval studies (Phase 4)UnknownNCT03755869
What this trial is testing

Study of Anlotinib in Non-squamous NSCLC Patients Who Failed First-Line（ALTER-L020）

Who this might be right for
Non-squamous NSCLC
First Affiliated Hospital Xi'an Jiaotong University 103
Testing effectiveness (Phase 2)UnknownNCT03591666
What this trial is testing

Anlotinib in Recurrent/Metastatic Head and Neck Adenocarcinomas

Who this might be right for
Head and Neck CarcinomaAdenocarcinomaRecurrent Disease+1 more
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University 51
Testing effectiveness (Phase 2)Looking for participantsNCT06945705
What this trial is testing

A Clinical Trial of Furmonertinib Combined With Anlotinib as First-line Treatment for Advanced NSCLC With EGFR-sensitive Mutations and Brain Metastasis

Who this might be right for
NSCLC
Henan Cancer Hospital 146
Next Page